Form 4: Aura Biosciences Director Acquires Shares and Options Through RSU Award and Stock Option Grant

Director David Michael Johnson acquired shares and options in Aura Biosciences through a restricted stock unit (RSU) award and a stock option grant.

Summary

• On June 20, 2024, David Michael Johnson, a director of Aura Biosciences, Inc., acquired 10,500 shares of common stock through a restricted stock unit (RSU) award.
• The RSUs will vest fully on the earlier of June 20, 2025, or the next annual meeting of the Issuer's stockholders, contingent upon continued service.
• Johnson also acquired a stock option to purchase 14,500 shares of common stock at an exercise price of $6.93.
• This stock option will vest and become exercisable in full upon the earlier of June 20, 2025, or the next annual meeting of the Issuer's stockholders, contingent upon continued service.
• Following these transactions, Johnson directly owns 146,167 shares of Aura Biosciences common stock.
• Johnson also indirectly owns 75,000 shares through the NEJ09 IRREVOCABLE TRUST, 75,000 shares through the NEJ12 IRREVOCABLE TRUST, and 139,672 shares through Velocity Capital Management.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares and options suggests confidence, but it's a routine transaction.

Positives

• The acquisition of shares and options by a director signals confidence in the company's future prospects.
• The vesting conditions tied to continued service align the director's interests with those of the shareholders.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the director's continued service, suggesting an expectation of ongoing involvement with the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.
• Employees may view the transaction positively as it indicates management's commitment.

Key Dates